3 Stocks to Watch in 2026 with Potential for High Growth

Three stocks have surged 56% YTD: Corvus Pharmaceuticals (CRVS), New Era Energy & Digital (NUAI), and USA Rare Earth (USAR). Corvus' soquelitinib trial data and planned Phase 2 trial have fueled a 188% YTD gain. Analysts expect 51% growth for CRVS, despite the $150-million equity offering. NUAI's data center pivot, including a partnership with Primary Digital Infrastructure, has contributed to its 114% YTD gain.